Status:
ACTIVE_NOT_RECRUITING
Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Hip Fractures
Hip Fracture Pathologic
Eligibility:
All Genders
18+ years
Brief Summary
This study will be based on a retrospective review of patients who received endoprosthetic reconstruction for pathologic fracture of the proximal femur. The objectives would be two-fold: (1) to compar...
Eligibility Criteria
Inclusion
- Participants have received endoprosthetic reconstruction for pathologic fracture of the proximal femur
Exclusion
- Participants with fractures greater than 3mm from the lesser trochanter
- Participants without histopathologic confirmation of tumor
Key Trial Info
Start Date :
August 4 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 4 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06935071
Start Date
August 4 2016
End Date
August 4 2026
Last Update
April 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065